Program Description: Pediatric sinusitis is a major source of patient referrals for the otolaryngologist. The issue of diagnosis and treatment differs from the adult with regard to pathophysiology, management, and patient cooperation. This seminar will focus on the current state of drugs and devices used to diagnose and treat pediatric sinusitis. The seminar will begin with the use of devices in children to diagnose chronic rhinosinusitis or differentiate rhinitis from sinusitis. Discussion will include the use of pediatric office endoscopy, endoscopic-guided cultures, CT scanning, pH probe testing and other devices. We will also discuss how they should be used in the office on children. The seminar will then progress to the use of drugs and devices in the management and treatment of pediatric sinusitis. This discussion will include adenoidectomy and associated devices, culture techniques, balloon sinus surgery, and associated minimally invasive devices as well as traditional endoscopic surgical techniques. Further discussion will focus on various endoscopic surgical drugs and devices applied to the pediatric patient both intraoperative and postoperative. Drugs discussed for the treatment and management of pediatric sinusitis will include intravenous antibiotics, topical aerosol therapy, mucolytic agents, steroids, and intranasal packing and stents. Presentations will also occur on the pediatric patient with special issues and sinusitis such as immunologic deficiencies and cystic fibrosis. This will be a presentation based on the current literature, extensive clinical experience and case studies. Panel discussions and opinion by pediatric otolaryngologist with extensive experience will be a major part of this seminar.
Educational Objectives: 1) Discuss and present drugs and medical devices currently used to diagnose and treat pediatric sinusitis. 2) Present current medical devices and techniques used to treat pediatric sinusitis in the operative setting. 3) Present current drugs and devices used to manage children with sinusitis and related medical disorders.
Practice Guideline: Polysomnography
Before Tonsillectomy in Children Peter S. Roland, MD (moderator); Richard M. Rosenfeld, MD, MPH; Ron B. Mitchell, MD; Norman R. Friedman, MD, DABSM Program Description: The miniseminar will consist of a lively panel discussion on the evidence-based recommendations for the use of polysomnography in managing patients with sleepdisordered breathing who are candidates for tonsillectomy, with or without adenoidectomy. The panel will discuss the newly developed AAO-HNS clinical practice guideline for otolaryngologists. The primary purpose of this guideline is to improve the referral patterns for polysomnography for candidates for tonsillectomy, 2 to 18 years of age, when tonsillectomy is recommended for SDB. In creating this guideline the AAO-HNSF selected a panel representing the fields of anesthesiology, pulmonology, otolaryngology-head and neck surgery, pediatrics, and sleep medicine. The committee made recommendations that 1) Before performing tonsillectomy, the clinician should refer children with SDB for PSG if they exhibit any of the following: obesity, Down syndrome, craniofacial abnormalities, neuromuscular disorders, sickle cell disease, or mucopolysaccharidoses; 2) The clinician should advocate for PSG prior to tonsillectomy for SDB in children without any of the comorbid conditions listed in statement No. 1 for whom the need for surgery is uncertain or when there is discordance between tonsillar size on physical examination and the reported severity of SDB; 3) Clinicians should communicate the results of PSG to the anesthesiologist prior to the induction of anesthesia for tonsillectomy in a child with SDB; 4) Clinicians should admit children with OSA documented on PSG for inpatient, overnight monitoring after tonsillectomy if they are under age 3 years or have severe OSA (apnea-hypopnea index of 10 or more obstructive events/hour, or have an oxygen saturation nadir less than 80%); and 5) In children for whom PSG is indicated to assess SDB prior to tonsillectomy, clinicians should obtain laboratory based PSG, when available, instead of portable monitoring (PM) with a home device. This guideline is intended to assist otolaryngologists-head and neck surgeons in making evidencebased decisions regarding PSG in children.
Educational Objectives: 1) Understand when clinicians should refer children with SDB for PSG. 2) Use PSG results to identify children with SDB admitted for overnight observation following tonsillectomy. 3) Know why PSG performed in sleep laboratory is preferred over home PSG with portable monitoring devices.
Redefining Pediatric Rhinosinusitis
Sanjay R. Parikh, MD (moderator); Rodney P. Lusk, MD; Scott C. Manning, MD; Harlan R. Muntz, MD Program Description: Over a decade has passed since the last comprehensive definition of pediatric rhinosinusitis was developed by an expert panel. In this miniseminar, international leaders in the field of pediatric rhinology will provide the latest evidence and experience regarding the definition of pediatric rhinosinusitis. Specifically, panelists will provide state-of-the-art concepts regarding pediatric rhinosinusitis including contributing factors such as allergy, antigens, fungus, biofilms, and reflux. The panel will discuss the differences between acute and chronic pediatric rhinosinusitis and provide the audience with guidelines for the clinical evaluation of both. Finally, with the use of case presentations, the panel will discuss contemporary medical and surgical interventions for acute and chronic pediatric rhinosinusitis.
Educational Objectives: 1) Understand the current definitions of acute and chronic pediatric rhinosinusitis. 2) Understand
